Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence

Immunocompromising conditions increase the risk of invasive pneumococcal disease (IPD). Vaccine uptake in patients with these conditions may be low in part because of concerns about decreased immunogenicity and safety in these high-risk groups. We conducted a literature search to identify publicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chilson, Erica, Scott, Daniel A., Schmoele-Thoma, Beate, Watson, Wendy, Moran, Mary M., Isturiz, Raul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746253/
https://www.ncbi.nlm.nih.gov/pubmed/32530360
http://dx.doi.org/10.1080/21645515.2020.1735224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746253/
https://www.ncbi.nlm.nih.gov/pubmed/32530360
http://dx.doi.org/10.1080/21645515.2020.1735224

Ejemplares similares